Pediatric Vaccines Market Updates

Pediatric Vaccines Market Competitive Landscape

To understand the competitive landscape, we are analyzing key Pediatric Vaccines Market vendors in the market. To understand the competitive rivalry, we are comparing the revenue, expenses, resources, product portfolio, region coverage, market share, key initiatives, product launches, and any news related to the Pediatric Vaccines Market.

To validate our hypothesis and validate our findings on the market ecosystem, we are also conducting a detailed porter's five forces analysis. Competitive Rivalry, Supplier Power, Buyer Power, Threat of Substitution, and Threat of New Entry each force is analyzed by various parameters governing those forces.

Key Players Covered in the Report:

• mainly focus on expanding their product portfolio and invest in mergers and acquisitions to capture a larger revenue share. For instance, GlaxoSmithKline plc, in 2015, acquired the vaccine business division of Novartis and received approval for two new vaccines-Infanrix and Boostrix, which provide immunization against diphtheria, tetanus, and pertussis.
• KEY MARKET SEGMENTS
• By Type
• Monovalent
• Multivalent
• By Technology
• Live Attenuated
• Inactivated
• Subunit
• Toxoid
• Conjugate
• Others
• By Application
• Infectious Disease
• Cancer
• Allergy
• By Region
• North America
• The U.S.
• Canada
• Europe
• Germany
• U.K.
• Asia Pacific
• China
• Japan
• India
• Latin America
• Middle East & Africa
• KEY PLAYERS
• GlaxoSmithKline plc
• Merck Sharp & Dohme Corp.
• SANOFI
• AstraZeneca
• Pfizer, Inc.
• Zydus Cadila
• Indian Immunologicals Limited
• Serum Institute of India Pvt. Ltd.
• Mitsubishi Tanabe Pharma Corporation
• Panacea Biotec
• Sinovac Biotech Ltd.
• Bio Med Pvt. Ltd.